Study to assess the bioavailability of ticagrelor OD tablet vs. IR tablet

Trial Identifier: D5139C00003
Sponsor: AstraZeneca
NCTID:: NCT02400333
Start Date: June 2015
Primary Completion Date: July 2015
Condition: Other; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Germany Berlin, Germany